Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review
- PMID: 25817052
- DOI: 10.1586/1744666X.2015.1029458
Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review
Abstract
Mesenchymal stem cells (MSC) are widely studied for their immunomodulatory properties. Data from in vitro and pre-clinical models demonstrate that MSC suppress activated immune cells and ameliorate the severity of experimental immune disease. In complex human studies, the immunomodulatory efficacy of MSC therapy is not well established. We conducted a systematic review of clinical studies which used MSC with the purpose of immunomodulation and included at least 10 patients to investigate the efficacy of MSC therapy. Sixty-two studies comprising 10 different immune disorders were included in the analysis, of which 18 studies represented controlled trials. Although several of the studies reported an amelioration of disease severity, other studies failed to observe a beneficial effect of MSC. The low number of randomized controlled trials, small number of studies per disease category and limited immunological readout parameters made it difficult to draw a definitive conclusion on the efficacy of MSC immune therapy.
Keywords: autoimmune disease; clinical trial; immune therapy; immunomodulation; mesenchymal stem cells; organ transplantation.
Similar articles
-
Are mesenchymal stromal cells immune cells?Arthritis Res Ther. 2015 Mar 31;17(1):88. doi: 10.1186/s13075-015-0596-3. Arthritis Res Ther. 2015. PMID: 25880839 Free PMC article. Review.
-
Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: A systematic review.Semin Arthritis Rheum. 2016 Aug;46(1):1-19. doi: 10.1016/j.semarthrit.2016.02.008. Epub 2016 Mar 7. Semin Arthritis Rheum. 2016. PMID: 27105756 Review.
-
Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo?Regen Med. 2015;10(3):305-15. doi: 10.2217/rme.15.14. Regen Med. 2015. PMID: 25933239 Review.
-
Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation.Curr Opin Organ Transplant. 2010 Dec;15(6):731-7. doi: 10.1097/MOT.0b013e328340172c. Curr Opin Organ Transplant. 2010. PMID: 20881495 Review.
-
Could mesenchymal stromal cells have a role in childhood autoimmune diseases?Immunol Invest. 2013;42(7):639-56. doi: 10.3109/08820139.2013.822393. Immunol Invest. 2013. PMID: 24004061 Review.
Cited by
-
Identification and Characterization of Human Endometrial Mesenchymal Stem/Stromal Cells and Their Potential for Cellular Therapy.Stem Cells Transl Med. 2016 Sep;5(9):1127-32. doi: 10.5966/sctm.2015-0190. Epub 2016 May 31. Stem Cells Transl Med. 2016. PMID: 27245365 Free PMC article. Review.
-
Immunogenic potential of human bone marrow mesenchymal stromal cells is enhanced by hyperthermia.Cytotherapy. 2018 Dec;20(12):1437-1444. doi: 10.1016/j.jcyt.2018.10.002. Epub 2018 Oct 31. Cytotherapy. 2018. PMID: 30389270 Free PMC article.
-
Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease?Thorax. 2018 Jun;73(6):565-574. doi: 10.1136/thoraxjnl-2017-210672. Epub 2018 Apr 13. Thorax. 2018. PMID: 29653970 Free PMC article. Review.
-
Improving Immunotherapy Through Glycodesign.Front Immunol. 2018 Nov 2;9:2485. doi: 10.3389/fimmu.2018.02485. eCollection 2018. Front Immunol. 2018. PMID: 30450094 Free PMC article. Review.
-
Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.Mol Ther. 2016 May;24(5):965-77. doi: 10.1038/mt.2016.12. Epub 2016 Jan 14. Mol Ther. 2016. PMID: 26765769 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
